Sonoma Pharmaceuticals (SNOA) Total Non-Current Liabilities: 2011-2012
Historic Total Non-Current Liabilities for Sonoma Pharmaceuticals (SNOA) over the last 2 years, with Mar 2012 value amounting to $6.7 million.
- Sonoma Pharmaceuticals' Total Non-Current Liabilities rose 96.42% to $11.9 million in Q3 2012 from the same period last year, while for Sep 2012 it was $11.9 million, marking a year-over-year increase of 96.42%. This contributed to the annual value of $6.7 million for FY2012, which is 7.93% up from last year.
- According to the latest figures from FY2012, Sonoma Pharmaceuticals' Total Non-Current Liabilities is $6.7 million, which was up 7.93% from $6.2 million recorded in FY2011.
- In the past 5 years, Sonoma Pharmaceuticals' Total Non-Current Liabilities ranged from a high of $6.7 million in FY2012 and a low of $6.2 million during FY2011.
- Its 2-year average for Total Non-Current Liabilities is $6.5 million, with a median of $6.5 million in 2011.
- Data for Sonoma Pharmaceuticals' Total Non-Current Liabilities shows a peak YoY rose of 7.93% (in 2012) over the last 5 years.
- Yearly analysis of 2 years shows Sonoma Pharmaceuticals' Total Non-Current Liabilities stood at $6.2 million in 2011, then rose by 7.93% to $6.7 million in 2012.